Slideshow

7 Mistakes in Treatment-Resistant Depression

Author(s):

Chris Aiken, MD

Raise the dose, augment, or switch? A new study suggests we may need to give antidepressants more time to be effective.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
McIntyre
John Krystal
brain connections
schism
electric brain
DBS
brain research
pills
brain
depression
Related Content
depression
June 27th 2025

ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial

Leah Kuntz
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
psilocybin
June 23rd 2025

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
antidepressants hesitation
June 5th 2025

Is Psychiatry Corrupt? Aftab and Antidepressants

Daniel Morehead, MD
sleepy somnolence
May 29th 2025

Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.